John "Jack" Thole, renowned chemistry teacher at Chicago's Saint Ignatius College Prep, dies at 89
John P. "Jack" Thole, a renowned chemistry teacher at Chicago's Saint Ignatius College Prep who also served for a time as science department chair of the Jesuit high school, died last month.
A published obituary said Thole, most recently of the south Chicago suburb of Frankfort, died April 10. He was 89.
Born in Cincinnati, Ohio, on Aug. 7, 1935, Thole attended St. Xavier High School and Xavier University in Cincinnati, where he earned a B.A. and M.S. in chemistry. He went on to join the Society of Jesus through the Milford Novitiate in Ohio and served as a Jesuit brother for 18 years, his obit noted.
Thole worked for Regis Technologies and Pelron Corporation as a chemist, his obit noted. But he found his true calling, and is remembered fondly by generations, as a high school chemistry teacher at Saint Ignatius.
Thole — known as Brother Thole to students while still a Jesuit and Mr. Thole after leaving the order — taught at Saint Ignatius in two stints going back to the 1960s. He was still teaching AP Chemistry by the 1997-1998 school year.
"Jack's love for the sciences dates back to one of his first Christmases when his father had purchased a basic chemistry set for him," Thole's obit read. "This sparked a curiosity and passion for science that would fuel his drive to enrich his students year later."
Mr. John "Jack" Thole, seen in the 1988 Saint Ignatius College Prep yearbook.
Saint Ignatius College Prep
Mr. Thole's students will remember his engaging and encouraging style of teaching. He had no patience for slacking off, but always congratulated students on a job well done.
Thole's former students will also remember his trademark expressions — "Clear as mud?" he would ask when he wanted to ensure a class understood a lesson. Beyond the concept of electrical charges and ionic bonds, Mr. Thole would also point out that if one had sprinkled our food with molecular chlorine and sodium atoms instead of the ionic compound that is table salt, one "would have died a long time ago" — with a reminder about sodium atoms' explosive reaction with water.
While teaching at Saint Ignatius, Thole received the 1975 Davidson Award from the Chemistry Council of Illinois as an outstanding high school chemistry teacher.
On social media this week, many of Thole's former students cited him as a favorite teacher who inspired a lifelong love of chemistry.
Thole served as science department chair, and also served a stint as principal during his time at Saint Ignatius, the school noted.
Thole's obit noted that he was an avid sportsman.
"From hunting prairie dogs across the country, or winning various shooting competitions, to enjoying a 'tube steak' while washing it down with the perfect Manhattan, Jack's infectious smile and booming laughter always brightened the darkest of rooms," his obit read.
Thole is survived by his wife of 42 years, Eleanore Ann, two stepchildren, six grandchildren, and three brothers. An archived Chicago Tribune report noted that Thole's daughter attended Saint Ignatius.
A funeral mass was held this past Saturday at Christ the King Church in Chicago's Beverly neighborhood.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
4 days ago
- New York Times
A Biotech Start-Up Promises Immortality. Is It All a Fraud?
NOTES ON INFINITY, by Austin Taylor In Austin Taylor's debut, 'Notes on Infinity,' the campus novel is reimagined as a start-up fairy tale: Two college students from different worlds meet, spend their days and nights enjoying a heady exchange of ideas, drop out of school, found a wildly successful company, and flame out in scandal. Zoe, a driven and polished undergraduate chemist at Harvard, takes up with Jack, who at first seems to be a flaky genius in the grand tradition. Together they hatch an idea for prolonging human life, and name their biotech company Manna. One of them is keeping secrets, however, and the speed of their success doesn't allow either the time or inclination to reflect. Readers will see Theranos and a bit of FTX in the novel's inspiration, allusions that serve to dramatize the psychology of ambition and denial, how fraud can begin as a desperate, temporary fix, and then grow as the cost of the deception builds and builds. Taylor doesn't make her founders' initial lie explicit until after their fall from grace, leaving the reader to suspect that the whole business has to be rotten but not knowing exactly how or where. Mostly the pages turn themselves, but at times the familiarity of the plot can be grating. This is the challenge of basing any narrative on current events: When you think you know where a story is going, it's harder to see the characters as people. The messy, complex bond between Zoe and Jack gives the events greater texture and dimension, though: They lie to protect not just themselves, but each other. In this campus novel, the allure of tech entrepreneurship has altered the social hierarchy, to a point. Jack is befriended by a rich student named Carter, whom he later overhears justifying their relationship to his rich friends as they place bets on which of their awkward, outsider classmates will be 'the next Zuck.' When your peers place bets on your future, you become not a friend, but an instrument of their strategy. After some initial throat clearing, Taylor's fast-paced writing captures the pressure of start-up culture, and the ease with which a founder can be separated from their own creation. Zoe and Jack divvy up their responsibilities to match their perceived talents: Jack as the chaotic scientist, Zoe as the articulate, organized and elegant face of Manna. All public scrutiny will fall on her, while Jack will enjoy the benefits of the tech visionary stereotype. This fits neatly with their respective upbringings: Zoe's father is an M.I.T. professor and her mother is the renowned hostess of his 'living room seminars,' where 6-year-old Zoe 'would sometimes answer one of his rhetorical questions or proposals in a small, high voice: 'Your reasoning sounds flawed,' or 'Did you check your math there, Daddy?' Everyone thought this was adorable.' Jack grew up poor and neglected in central Maine; Harvard is his chance to escape, until he wants to escape it, too. Want all of The Times? Subscribe.
New York Times
29-05-2025
- New York Times
Robert Jarvik, 79, Dies; a Designer of the First Permanent Artificial Heart
Dr. Robert K. Jarvik, the principal designer of the first permanent artificial heart implanted in a human — a procedure that became a subject of great public fascination and fierce debate about medical ethics — died on Monday at his home in Manhattan. He was 79. His wife, the writer Marilyn vos Savant, said the cause was complications of Parkinson's disease. In 1982, the U.S. Food and Drug Administration gave the University of Utah permission to implant what was designed to be a permanent artificial heart in a human. On Dec. 2 that year, Dr. William C. DeVries led the pioneering surgical team that implanted the Jarvik-7 model, made of aluminum and plastic, in a 61-year-old retired Seattle dentist, Barney B. Clark. Dr. Clark at first declined to receive the Jarvik-7, Dr. DeVries was quoted as saying in a 2012 university retrospective, but he changed his mind on Thanksgiving after he had to be carried by a son to the dinner table. Dr. Clark's chronic heart disease had left him weeks from death. If the surgery didn't work for him, he told doctors, maybe it would help others. During the seven-hour surgery, according to the retrospective, Dr. Clark's heart muscle tore like tissue paper as it was removed after so many years of being treated with steroids. Upon awakening, Dr. DeVries said, Dr. Clark told his wife, Una Loy Clark, 'I want to tell you even though I have no heart, I still love you.' Dr. Clark survived for 112 days, attached to a 400-pound air compressor, roughly the size of a dishwasher, that helped the Jarvik-7 pump blood through his body. But he never left the hospital, and he experienced seizures, kidney failure and a broken valve on the heart that needed replacing. Dr. DeVries said in 2012 that Dr. Clark had probably received too many antibiotics, which can make it more difficult to fight off infections. He died on March 23, 1983, from complications related to a bacterial infection of the colon. William J. Schroeder, 52, a retired federal worker who was the second patient to receive the experimental Jarvik-7 artificial heart, lived for 620 days before dying in 1986. Another early recipient of the Jarvik-7, Murray P. Haydon, lived for 488 days before dying at 59. Their survival demonstrated that people 'could live long term on the plastic and metal device,' The New York Times reported upon Mr. Schroeder's death. But the newspaper added that strokes and other complications that recipients suffered 'impaired the quality of their lives and blunted initial enthusiasm for the heart.' Dozens — by some accounts hundreds — of reporters showed up at the University of Utah hospital to cover Barney Clark's surgery. Some celebrated the news, comparing the breakthrough to man's first walk on the moon. Others, however, criticized what they called the 'Frankenstein'-like aspects of the Jarvik-7 and asked whether the medical team was trying to play God by deciding who received the artificial heart. By the mid-1980s, medical ethicists and theologians were debating whether artificial hearts improved life or extended a painful decline toward death. At a 1985 symposium of religious figures and doctors in Louisville, Ky., a Jesuit theologian noted that in the Christian view, 'life is a basic good but not an absolute good,' adding, 'There is a limit on what we may do to preserve our lives.' After five patients received the Jarvik-7 as a permanent artificial heart, Dr. Jarvik said, the device was used hundreds of times as a temporary implant for patients until they could receive a donor heart. One such patient lived 11 years after receiving his donor heart, he said; another lived 14. In January 1990, the Food and Drug Administration withdrew its approval of the Jarvik-7, citing concerns about the manufacturer's quality control. In a 1989 interview with Syracuse University Magazine, Dr. Jarvik admitted that his belief that the Jarvik-7 was advanced enough to be used widely on a permanent basis was 'probably the biggest mistake I have ever made.' Still, he defended his work. Of the five recipients of the permanent Jarvik-7, he told the magazine, 'These were people who I view as having had their lives prolonged,' adding that they survived nine months on average when some had been expected to live 'no more than a week.' 'I don't think that kind of thing makes a person in medicine want to stop,' he said. 'It just makes you all the more interested in working it through so it can be better.' Robert Koffler Jarvik was born on May 11, 1946, in Midland, Mich., and grew up in Stamford, Conn. His father, Norman, was a physician with a family practice. His mother, Edythe (Koffler) Jarvik, handled scheduling for the practice and later taught typing. From an early age, Robert was a tinkerer. As a teenager, he made his own hockey mask and began developing a surgical stapler. He attended Syracuse University from 1964 until 1968, intending to study architecture, but his interest turned to medicine after his father survived an aortic aneurysm, and he received a degree in zoology. Dr. Norman Jarvik died in 1976 after a second aneurysm. 'I knew that my father was going to die of heart disease, and I was trying to make a heart for him,' Robert Jarvik once said. 'I was too late.' He studied medicine at the University of Bologna in Italy for two years and received a master's degree in occupational biomechanics from New York University before moving to the University of Utah in 1971. He received his medical degree there in 1976, but he did not follow the traditional career path of internship and residency. He was more interested in developing an artificial heart. Working with Dr. Willem J. Kolff, director of the university's Division of Artificial Organs, Dr. Jarvik designed a series of mechanical heart. One of them, according to an article in The New York Times in 1982, was implanted in a cow named Alfred Lord Tennyson, who survived for 268 days, a record for an animal. In 1985, Dr. Jarvik married Ms. Vos Savant, who was listed in Guinness World Records in the 1980s as having the highest recorded I.Q. (228). She survives him, as do his daughter, Kate Jarvik Birch, and his son, Tyler Jarvik, from his marriage to Elaine Levin, whom he married in 1968 and divorced in 1985; Ms. Vos Savant's two children, Mary (Younglove) Blinder and Dennis Younglove, from a previous relationship; a sister, Barbara Jarvik, and a brother, Jonathan Jarvik; and five grandchildren. In 2008, Dr. Jarvik faced scrutiny from a congressional committee that was investigating whether Pfizer misrepresented his credentials in an advertising campaign in which he served as a spokesman for Lipitor, the cholesterol medication. Pfizer ended the campaign. In the late 1980s, his company, Jarvik Heart Inc., began developing smaller, less obtrusive implements, known as ventricular assist devices. Unlike the Jarvik-7, these devices do not replace a diseased heart but assist in pumping blood from the lower chambers of the heart to the rest of the body. One such device, the Jarvik 2000, is about the size of a C battery. A pediatric version, called the Jarvik 2015, is roughly the size of an AA battery. According to a 2023 study of the artificial heart market, a descendant of the original Jarvik-7, now owned by another company, is called the SynCardia Total Artificial Heart. It is designed primarily for temporary use in patients who face imminent death while awaiting transplants. The study found that the device had been implanted in more than 1,700 patients worldwide. In 2018, Dr. Jarvik received a lifetime achievement award at the annual Medical Design Excellence Awards ceremony. In an interview this week, Dr. O.H. Frazier, an innovator in heart surgery in Houston who helped develop the Jarvik 2000, called him 'a genius.' 'He had an agile mind,' Dr. Frazier said, 'and made a great contribution to the care of heart-failure patients.'
New York Times
28-05-2025
- New York Times
16 States Sue Trump Over $1.4 Billion in Science Cuts
Sixteen states sued the Trump administration on Wednesday, asking a federal court to block cuts in programs and funding for the National Science Foundation that they argue are critical to maintaining the United States' position as a global leader in science, technology, engineering and math. The states sought the court order on grounds that the foundation's actions violated the law and would cause immediate and irreparable harm to the states involved in the lawsuit. The foundation last month began ending projects that were focused on increasing the participation of women, minorities and people with disabilities in STEM fields, and this month, it said it would cap indirect research costs, like laboratory space and equipment, at 15 percent of granted funds, according to the lawsuit. The states said in court papers that the cuts were 'in complete derogation of the policies and priorities set by Congress.' More than 1,700 research grants at the N.S.F. had been canceled as of Wednesday, according to a list published by the foundation, which amounts to $1.4 billion worth of cuts. 'This administration's attacks on basic science and essential efforts to ensure diversity in STEM will weaken our economy and our national security,' said Attorney General Letitia James of New York, who is leading the legal challenge filed in Federal District Court in Manhattan. 'Putting politics over science will only set our country back,' Ms. James said. A spokeswoman for the National Science Foundation declined to comment on the lawsuit. The federal government has worked to broaden participation of women and minorities in science and technology since at least 1980, upon direction from Congress. According to the lawsuit, that directive has been substantively amended only to also explicitly include people with disabilities. In court papers, the coalition of states said the foundation's directive to cap indirect costs at 15 percent for all N.S.F. research projects awarded to universities would be devastating. The State University of New York, for instance, would lose $18 million, the lawsuit says. Established in 1950, the N.S.F. funds much of the scientific research in the United States. In fiscal year 2024, the agency had a $9 billion budget. The Trump administration's draft budget, published earlier this month, proposed slashing those funds by 55.8 percent. The lawsuit comes amid a series of changes at the foundation as it tries to align its policies with those of the Trump administration, including issuing an updated statement of priorities to exclude the funding of activities supporting diversity, equity and inclusion. Days after the award terminations began, the director of the N.S.F., Sethuraman Panchanathan, announced his resignation. In addition to New York, the other states joining in the lawsuit were California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maryland, Massachusetts, Nevada, New Jersey, New Mexico, Oregon, Rhode Island, Wisconsin and Washington.
